Segelmark, MÃ¥rten |
| Active, not recruiting | 3 | 50 | Europe, US, RoW | Imlifidase, IdeS, HMED-IdeS, Plasma exchange (PLEX), PE, Cyclophosphamide (CYC), Glucocorticoids | Hansa Biopharma AB | Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome | 06/25 | 11/26 | | |
SACK, NCT05679024: Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation |
|
|
| Recruiting | 3 | 1400 | Europe, RoW | Apixaban 2.5 milligram Oral Tablet | Region Stockholm, Uppsala University | Chronic Kidney Diseases, Atrial Fibrillation, Stroke, Intracerebral Hemorrhage, Major Bleed, Cardiovascular Complication, Death, Kidney Transplant; Complications, Thromboses, Venous | 12/27 | 12/28 | | |
Brummer, Robert J |
NCT03918330: Spatial Analysis of the Intestinal Microbiota in Healthy Subjects |
|
|
| Active, not recruiting | N/A | 10 | Europe | | Örebro University, Sweden, Region Örebro County | Healthy Subjects | 02/19 | 12/24 | | |
NCT03920410: Effect of Serotonergic Stimulation on the Gut-brain Axis |
|
|
| Active, not recruiting | N/A | 58 | Europe | serotonergic stimulation, no serotonergic stimulation | Örebro University, Sweden, Region Örebro County | Healthy, Irritable Bowel Syndrome | 03/22 | 12/24 | | |
NCT05058131: Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre |
|
|
| Recruiting | N/A | 40 | Europe | Dietary fibre, Placebo compound | Örebro University, Sweden | Microscopic Colitis | 12/22 | 12/22 | | |
NCT05611138: Dietary Proteins: Metagenomic and Metabolomics Approaches for Human Biomarkers Identification |
|
|
| Completed | N/A | 59 | Europe | Protein supplementation | Örebro University, Sweden | Healthy | 04/23 | 04/23 | | |
NCT05421793: Prebiotic and Anti-inflammatory Effects of a Pectin Polysaccharide |
|
|
| Completed | N/A | 17 | Europe | Fermented product of carrot derived rhamnogalacturonan I | Örebro University, Sweden, NutriLeads B.V. (Wageningen, The Netherlands) | Healthy | 07/23 | 08/23 | | |
NCT05801042: Effect of Encapsulated Vs Free Probiotic on Brain Function |
|
|
| Completed | N/A | 91 | Europe | Maltodextrin, Encapsulated Lactocaseibacillus rhamnosus, Non-encapsulated Lactocaseibacillus rhamnosus | Robert Brummer | Aging | 11/23 | 09/24 | | |
| Recruiting | N/A | 11 | Europe | Oat Protein, low bioavailability, Oat Protein, high bioavailability, Pea Protein, low bioavailability, Pea Protein, high bioavailability, Protein-free meal | Örebro University, Sweden | Ileostomy - Stoma | 12/24 | 12/24 | | |
| Recruiting | N/A | 75 | Europe | Maltodextrin, Chicory RG-I, Carrot RG-I | Örebro University, Sweden, NutriLeads B.V. (Wageningen, The Netherlands), ProDigest (Ghent, Belgium), Ambiotis (Toulouse, France) | Healthy | 04/24 | 12/24 | | |
| Active, not recruiting | N/A | 28 | Europe | Isolated Pea Protein, Isolated Whey Protein, Isolated Faba Bean Protein, Placebo | Örebro University, Sweden | Healthy | 05/24 | 05/24 | | |
| Enrolling by invitation | N/A | 120 | Europe | | Örebro University, Sweden, VHIR, Aston University, Region Örebro County | Parkinson Disease, Irritable Bowel Syndrome | 10/27 | 10/27 | | |
Stenberg, Erik |
| Recruiting | 4 | 120 | Europe, Canada, US, RoW | Metabolic surgery, Bariatric surgery, Roux-en-Y Gastric Bypass (RYGB), Sleeve Gastrectomy (SG), Incretin-Based Therapy, Glucagon-like Peptide-1 Receptor Agonist | Ali Aminian | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Obesity | 05/29 | 12/29 | | |
ANTILOP, NCT04147000: Pharmacokinetics and Pharmacodynamics of Oral Sertraline Before and After Bariatric Surgery |
|
|
| Terminated | N/A | 3 | Europe | | Linkoeping University, Örebro University, Sweden | Overweight, Depression, Anxiety Disorders | 11/23 | 11/23 | | |
Szabó, Barna |
| Recruiting | 3 | 2000 | Europe, US | Spironolactone, Standard care | Uppsala University, Karolinska University, Duke Clinical Research Institute, National Heart, Lung, and Blood Institute (NHLBI) | Heart Failure With Preserved Ejection Fraction | 12/26 | 12/26 | | |
Valachis, Antonis |
ASF-BC, NCT06152471: Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer |
|
|
| Recruiting | 3 | 100 | Europe | SPC-flakes, Salovum, Placebo | Henrik Lindman | Early-stage Breast Cancer, Diarrhea, Adverse Drug Event | 10/24 | 03/25 | | |
| Recruiting | 3 | 325 | Europe | epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, platinum, epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, antimetabolite, platinum | Lund University Hospital, Swedish Breast Cancer Group, Danish Breast Cancer Cooperative Group | Breast Cancer, Triple Negative Breast Neoplasms | 07/25 | 06/35 | | |
| Active, not recruiting | 3 | 368 | Europe, US, RoW | Abemaciclib, Fulvestrant, Placebo | Eli Lilly and Company, Eli Lilly and Company | Breast Neoplasm, Neoplasm Metastasis | 02/24 | 02/26 | | |
| Not yet recruiting | 3 | 3832 | Europe | Letrozole, Anastrozole, Exemestane, Tamoxifen | Region Örebro County, Mid-Sweden Regional Cancer Centre, Akademiska University Hospital, Uppsala, Sweden | Breast Cancer | 05/32 | 05/35 | | |
QPL, NCT06777420: Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 218 | Europe | Question prompt list | Region Örebro County | Breast Cancer Early Stage Breast Cancer (Stage 1-3), Neoadjuvant Therapy, Shared Decision Making | 01/27 | 02/27 | | |
TRIM, NCT03116412: A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma |
|
|
| Recruiting | N/A | 1300 | Europe | CT or PET scans | Uppsala University | Malignant Melanoma | 12/28 | 12/28 | | |
Nordenskjöld, Axel |
NCT04057378: Optimal Electrical Stimulus During Electroconvulsive Therapy |
|
|
| Recruiting | 4 | 800 | Europe | Electroconvulsive therapy, ECT | Region Örebro County | Depressive Disorder, Major, Depression, Bipolar | 11/25 | 11/25 | | |
| Recruiting | 2 | 100 | Europe | psilocybin 25 mg sod, psilocybin 1 mg sod | Section for Affective Disorders; Northern Stockholm Psychiatry, Uppsala University Hospital, Region Örebro County, Vastra Gotaland Region, Karolinska Institutet | MDD | 12/25 | 12/25 | | |
| Recruiting | 2 | 120 | Europe | Rituximab, Saline | Region Örebro County | Schizophrenia Spectrum and Other Psychotic Disorders | 06/26 | 12/26 | | |
Furuland, Hans |
SACK, NCT05679024: Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation |
|
|
| Recruiting | 3 | 1400 | Europe, RoW | Apixaban 2.5 milligram Oral Tablet | Region Stockholm, Uppsala University | Chronic Kidney Diseases, Atrial Fibrillation, Stroke, Intracerebral Hemorrhage, Major Bleed, Cardiovascular Complication, Death, Kidney Transplant; Complications, Thromboses, Venous | 12/27 | 12/28 | | |
| Recruiting | 2 | 30 | Europe | Aliskiren, Enalapril | Region Skane | C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality, Dense Deposit Disease, C3 Glomerulonephritis | 12/29 | 12/29 | | |
Wickbom, Malin |
NCT06453590: Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents |
|
|
| Recruiting | N/A | 450 | Europe | Randomization to uncovered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to partially covered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to fully covered SEMS treating jaundice due to distal malignant biliary obstruction. | Region Stockholm | Pancreatic Cancer Non-resectable, Bile Duct Cancer, Papillary Carcinoma, Duodenal Cancer | 01/25 | 01/26 | | |
Nieuwenhoven, Michiel van |
NCT04859972: How Well do Primary Care Doctors in Region Örebro County, Sweden Follow Diagnostic Guidelines of IBS? |
|
|
| Not yet recruiting | N/A | 3000 | NA | Diagnosis of IBS | Region Örebro County | Irritable Bowel Syndrome | 08/22 | 05/23 | | |
| Not yet recruiting | N/A | 200 | Europe | Internet based cognitive behavioral therapy., Low FODMAP diet therapy | Region Örebro County | Irritable Bowel Syndrome | 03/24 | 05/26 | | |
NCT05185609: Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease |
|
|
| Recruiting | N/A | 70 | Europe | Exposure 1: Visceral hypersensitivity or phenotype suggestive of IBS, Exposure 2: Changes in anorectal motor function or compliance. | Region Örebro County | Inflammatory Bowel Diseases, Irritable Bowel Syndrome | 12/27 | 12/27 | | |
| Not yet recruiting | N/A | 3000 | NA | | Region Örebro County | Irritable Bowel Syndrome | 05/23 | 05/24 | | |
NCT05144594: Direct Medical Costs Associated With Negative Diagnosis of IBS. |
|
|
| Not yet recruiting | N/A | 3000 | NA | | Region Örebro County | Irritable Bowel Syndrome | 05/24 | 05/25 | | |
Grando, Lucian Marinica |
NCT05185609: Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease |
|
|
| Recruiting | N/A | 70 | Europe | Exposure 1: Visceral hypersensitivity or phenotype suggestive of IBS, Exposure 2: Changes in anorectal motor function or compliance. | Region Örebro County | Inflammatory Bowel Diseases, Irritable Bowel Syndrome | 12/27 | 12/27 | | |
Flesche, Jan |
SACK, NCT05679024: Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation |
|
|
| Recruiting | 3 | 1400 | Europe, RoW | Apixaban 2.5 milligram Oral Tablet | Region Stockholm, Uppsala University | Chronic Kidney Diseases, Atrial Fibrillation, Stroke, Intracerebral Hemorrhage, Major Bleed, Cardiovascular Complication, Death, Kidney Transplant; Complications, Thromboses, Venous | 12/27 | 12/28 | | |
Christenssen, Anders |
SACK, NCT05679024: Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation |
|
|
| Recruiting | 3 | 1400 | Europe, RoW | Apixaban 2.5 milligram Oral Tablet | Region Stockholm, Uppsala University | Chronic Kidney Diseases, Atrial Fibrillation, Stroke, Intracerebral Hemorrhage, Major Bleed, Cardiovascular Complication, Death, Kidney Transplant; Complications, Thromboses, Venous | 12/27 | 12/28 | | |
Jacuszewski, Piotr |
SACK, NCT05679024: Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation |
|
|
| Recruiting | 3 | 1400 | Europe, RoW | Apixaban 2.5 milligram Oral Tablet | Region Stockholm, Uppsala University | Chronic Kidney Diseases, Atrial Fibrillation, Stroke, Intracerebral Hemorrhage, Major Bleed, Cardiovascular Complication, Death, Kidney Transplant; Complications, Thromboses, Venous | 12/27 | 12/28 | | |